NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

CVRx, Inc. (CVRX) Stock Analysis

CVRx, Inc. (CVRX) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

CVRX

$1.37

−$0.02 (−1.44%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CVRX with… →

CVRX Key Statistics

As of Oct 21, 2026
Trading
Open
$1.38
Previous Close
$1.39
Day's Range
1.30–1.38
52-Week Range
1.26–11.30
Volume
281.96K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.77
Valuation
Market Cap
$36.50M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.60
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.97
Financials (FY)
Revenue (FY)
$56.65M+10.45%
Net Income (FY)
−$53.31M
Profit marginThe share of revenue left as profit after all costs and taxes.
−84.93%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
26.64M
1-Year Return
−86.40%
Dividend and dates
Earnings Date
November 5, 2026estimated
Avg Volume
942.97K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, CVRX closed at $1.37, −86.40% over 1 year.

CVRx, Inc. (CVRX) has a market capitalization of $36.50M.

In fiscal 2025, CVRX reported revenue of $56.65M.

CVRX Stock Return by Calendar Year

CVRx, Inc. (CVRX) return since Jun 2021: what $10,000 became

1 year
$10,000 $1,360
−86.40%
5 years
$10,000 $875
−91.25%
Since Jun 2021
$10,000 $489
−95.11%

If you had invested $10,000 in CVRx, Inc. (CVRX) at the close on June 30, 2021, the earliest close on record here, it would have been worth $489 at the close on October 21, 2026: −95.11% in total, −43.36% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−80.70%
2025−43.96%
2024−59.70%
2023+71.34%
2022+50.04%
2021 (partial year)−56.32%

As of October 21, 2026.

CVRX Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$56.65M−$53.31M−94.1%
2024$51.29M−$59.97M−116.9%
2023$39.30M−$41.20M−104.8%
2022$22.47M−$41.43M−184.4%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$56.65M$48.34M−$51.27M−$53.31M−94.1%
2024$51.29M$42.96M−$59.49M−$59.97M−116.9%
2023$39.30M$33.04M−$43.10M−$41.20M−104.8%
2022$22.47M$17.47M−$42.53M−$41.43M−184.4%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

CVRX Valuation vs Medical Devices Median

Median of 145 stocks
MetricCVRXMedical Devices medianvs median
P/S ratio0.602.530.2x the median
Profit margin−84.93%−14.78%70.2 pts below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 16 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

CVRx, Inc. (CVRX) is capitalised at $36.50M on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 223.

The most recent close on file for CVRX is $1.37, dated October 21, 2026. That is −$0.02 (−1.44%) against the previous close. The 52-week range on file runs from $1.26 to $11.30. The latest close sits 9.16% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $56.65M. That is +10.45% against the prior fiscal year, when revenue was $51.29M. The same year closed with a net loss of $53.31M. The reported profit margin is −84.93%. That is 70.2 percentage points below the Medical Devices median of −14.78%. Trailing earnings per share are −1.97.

Across the 4 fiscal years on file, revenue moves from $22.47M in 2022 to $56.65M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The price-to-sales ratio is 0.6. On price-to-sales that is 0.2 times the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

The reported beta is 0.77. Daily returns over the trailing 5 years annualize to a volatility of 95.91%. Over the trailing twelve months the total return is −86.40%. Across 5 years the annualized return works out at −38.56%.

Growth & Income

The record shows no dividend for CVRX.

2026 is still running; the total return is −80.70% year to date. Across the complete calendar years on file, 2023 returned +71.34% and 2024 returned −59.70%. Of the 4 complete calendar years on file, 2 finished higher.

Peer Comparison

CVRx, Inc. (CVRX) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
CVRx, Inc. CVRX $36.50M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. CVRx, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About CVRx, Inc.

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Visit website →